This activity is supported by educational funding provided by Amgen and Merck Sharp & Dohme Corp.
On-demand 4-part Medical Crossfire
Adoption of Biosimilars: Prescriber, Pharmacy and Payer Perspectives
This 4-part online CE-accredited activity will serve as an update on the clinical options in Biosimilars and the changing environment for clinicians, specialty pharmacists, and payers. To view each activity, click on the hyperlinks below.